91 related articles for article (PubMed ID: 25599774)
1. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.
Yonal O; Eren F; Yılmaz Y; Atuğ Ö; Över HH
Turk J Gastroenterol; 2014 Dec; 25(6):639-43. PubMed ID: 25599774
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
Strisciuglio C; Bellini G; Miele E; Martinelli M; Cenni S; Tortora C; Tolone C; Miraglia Del Giudice E; Rossi F
J Clin Gastroenterol; 2018; 52(5):e37-e43. PubMed ID: 27875353
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.
Rossi F; Bellini G; Tolone C; Luongo L; Mancusi S; Papparella A; Sturgeon C; Fasano A; Nobili B; Perrone L; Maione S; del Giudice EM
Pharmacol Res; 2012 Jul; 66(1):88-94. PubMed ID: 22465144
[TBL] [Abstract][Full Text] [Related]
4. Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.
Ismail M; Khawaja G
Clin Rheumatol; 2018 Nov; 37(11):2933-2938. PubMed ID: 30032418
[TBL] [Abstract][Full Text] [Related]
5. Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.
Bellini G; Olivieri AN; Grandone A; Alessio M; Gicchino MF; Nobili B; Perrone L; Maione S; del Giudice EM; Rossi F
Scand J Rheumatol; 2015; 44(4):284-7. PubMed ID: 25974389
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt.
Mahmoud Gouda H; Mohamed Kamel NR
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):247-51. PubMed ID: 23406660
[TBL] [Abstract][Full Text] [Related]
7. Methylenetetrahydrofolate reductase C677T variant in Moroccan patients with inflammatory bowel disease.
Senhaji N; Serbati N; Diakité B; Arazzakou S; Hamzi K; Badre W; Nadifi S
Gene; 2013 May; 521(1):45-9. PubMed ID: 23542077
[TBL] [Abstract][Full Text] [Related]
8. Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.
Eloranta JJ; Wenger C; Mwinyi J; Hiller C; Gubler C; Vavricka SR; Fried M; Kullak-Ublick GA;
Pharmacogenet Genomics; 2011 Sep; 21(9):559-64. PubMed ID: 21832969
[TBL] [Abstract][Full Text] [Related]
9. IL-1 receptor antagonist (IL-1Ra) gene polymorphism in patients with inflammatory bowel disease in India.
Mittal RD; Bid HK; Ghoshal UC
Scand J Gastroenterol; 2005 Jul; 40(7):827-31. PubMed ID: 16109659
[TBL] [Abstract][Full Text] [Related]
10. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases.
Saibeni S; Spina L; Virgilio T; Folcioni A; Borsi G; de Franchis R; Cugno M; Vecchi M
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):976-81. PubMed ID: 18049167
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.
Tahamtan A; Rezaiy S; Samadizadeh S; Moradi A; Tabarraei A; Javid N; Oladnabi M; Naeimi MH
J Mol Neurosci; 2020 Jan; 70(1):26-31. PubMed ID: 31407233
[TBL] [Abstract][Full Text] [Related]
13. The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.
Bellini G; Grandone A; Torella M; Miraglia del Giudice E; Nobili B; Perrone L; Maione S; Rossi F
PLoS One; 2015; 10(10):e0140142. PubMed ID: 26447698
[TBL] [Abstract][Full Text] [Related]
14. Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.
Rastegar M; Samadizadeh S; Yasaghi M; Moradi A; Tabarraei A; Salimi V; Tahamtan A
Arch Virol; 2021 Nov; 166(11):3117-3126. PubMed ID: 34514519
[TBL] [Abstract][Full Text] [Related]
15. Role of Cannabinoid CB2 Receptor Gene (CNR2) Polymorphism in Children with Immune Thrombocytopenic Purpura in Beni-Suef Governorate in Egypt.
Ezzat DA; Hammam AA; El-Malah WM; Khattab RA; Mangoud EM
Egypt J Immunol; 2017 Jan; 24(1):57-66. PubMed ID: 29120578
[TBL] [Abstract][Full Text] [Related]
16. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
Coppola N; Zampino R; Bellini G; Macera M; Marrone A; Pisaturo M; Boemio A; Nobili B; Pasquale G; Maione S; Adinolfi LE; Perrone L; Sagnelli E; Miraglia Del Giudice E; Rossi F
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):334-40. PubMed ID: 23707465
[TBL] [Abstract][Full Text] [Related]
17. Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease.
Celik Y; Dagli U; Kiliç MY; Törüner M; Ozen SC; Ozkan M; Soykan I; Cetinkaya H; Ulker A; Ozden A; Bozdayi AM
Scand J Gastroenterol; 2006 May; 41(5):559-65. PubMed ID: 16638698
[TBL] [Abstract][Full Text] [Related]
18. Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.
Heresbach D; Alizadeh M; Dabadie A; Le Berre N; Colombel JF; Yaouanq J; Bretagne JF; Semana G
Am J Gastroenterol; 1997 Jul; 92(7):1164-9. PubMed ID: 9219791
[TBL] [Abstract][Full Text] [Related]
19. The association between three promoter polymorphisms of IL-10 and inflammatory bowel diseases (IBD): a meta-analysis.
Zou L; Wang L; Gong X; Zhao H; Jiang A; Zheng S
Autoimmunity; 2014 Feb; 47(1):27-39. PubMed ID: 24128120
[TBL] [Abstract][Full Text] [Related]
20. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
